Literature DB >> 10749605

Extracorporeal perfusion for the treatment of acute liver failure.

H B Stockmann1, C A Hiemstra, R L Marquet, J N IJzermans.   

Abstract

OBJECTIVE AND SUMMARY BACKGROUND DATA: Because of the shortage of available donor organs, death rates from liver failure remain high. Therefore, several temporary liver-assisting therapies have been developed. This article reviews various approaches to temporary liver support as well as immunologic and metabolic developments toward a solution for this problem.
METHODS: A literature review was performed using Medline and additional library searches to obtain further references. Only articles with a well-defined aim of study and methodology and a clear description of the outcome of the experiments were included.
CONCLUSIONS: Renewed interest has developed in old and new methods for an extracorporeal approach to the treatment of acute liver failure. Although temporary clinical improvement has been established, further research is needed to achieve a successful long-term clinical outcome. New developments in the field of genetic modification and tissue engineering await clinical application in the near future.

Entities:  

Mesh:

Year:  2000        PMID: 10749605      PMCID: PMC1421020          DOI: 10.1097/00000658-200004000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  82 in total

1.  Continuous removal of middle molecules by hemofiltration in patients with acute liver failure.

Authors:  S Matsubara; K Okabe; K Ouchi; Y Miyazaki; Y Yajima; H Suzuki; M Otsuki; S Matsuno
Journal:  Crit Care Med       Date:  1990-12       Impact factor: 7.598

2.  Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure.

Authors:  A J Ellis; R D Hughes; J A Wendon; J Dunne; P G Langley; J H Kelly; G T Gislason; N L Sussman; R Williams
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

3.  Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.

Authors:  F D Watanabe; C J Mullon; W R Hewitt; N Arkadopoulos; E Kahaku; S Eguchi; T Khalili; W Arnaout; C R Shackleton; J Rozga; B Solomon; A A Demetriou
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

4.  Hybrid bioartificial liver in hepatic failure: preliminary clinical report.

Authors:  K N Matsumura; G R Guevara; H Huston; W L Hamilton; M Rikimaru; G Yamasaki; M S Matsumura
Journal:  Surgery       Date:  1987-01       Impact factor: 3.982

5.  Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration.

Authors:  J C Dunn; M L Yarmush; H G Koebe; R G Tompkins
Journal:  FASEB J       Date:  1989-02       Impact factor: 5.191

6.  Attachment and long term survival of adult rat hepatocytes in primary monolayer cultures: comparison of different substrata and tissue culture media formulations.

Authors:  H O Jauregui; P N McMillan; J Driscoll; S Naik
Journal:  In Vitro Cell Dev Biol       Date:  1986-01

7.  Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

Authors:  J G O'Grady; A E Gimson; C J O'Brien; A Pucknell; R D Hughes; R Williams
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

8.  Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora.

Authors:  U Galili; R E Mandrell; R M Hamadeh; S B Shohet; J M Griffiss
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

9.  A hybrid bioartificial liver composed of multiplated hepatocyte monolayers.

Authors:  J Uchino; T Tsuburaya; F Kumagai; T Hase; T Hamada; T Komai; A Funatsu; E Hashimura; K Nakamura; T Kon
Journal:  ASAIO Trans       Date:  1988 Oct-Dec

10.  The humoral immune response in humans following cross-perfusion of porcine organs.

Authors:  A H Cotterell; B H Collins; W Parker; R C Harland; J L Platt
Journal:  Transplantation       Date:  1995-10-27       Impact factor: 4.939

View more
  13 in total

Review 1.  [Liver replacement therapy. Reliable indications in acute liver failure].

Authors:  K Rifai; M Ott; M M Bahr; A Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 2.  Artificial and bioartificial support systems for liver failure.

Authors:  J P Liu; L L Gluud; B Als-Nielsen; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2004

3.  Influence of 3D porous galactose containing PVA/gelatin hydrogel scaffolds on three-dimensional spheroidal morphology of hepatocytes.

Authors:  Kirthanashri S Vasanthan; Anuradha Subramaniam; Uma Maheswari Krishnan; Swaminathan Sethuraman
Journal:  J Mater Sci Mater Med       Date:  2015-01-13       Impact factor: 3.896

Review 4.  Extracorporeal liver support in severe alcoholic hepatitis.

Authors:  Albert Parés; Antoni Mas
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

5.  New type of artificial liver support system (ALSS) using the photocatalytic effect of titanium oxide.

Authors:  Hisamitsu Shinohara; Mitsuo Shimada; Tetsuya Ikemoto; Yuji Morine; Satoru Imura; Masahiko Fujii; Takahumi Imaizumi; Michio Murayama; Yoshiro Aiba
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

Review 6.  Clinical application of bioartificial liver support systems.

Authors:  Maarten Paul van de Kerkhove; Ruurdtje Hoekstra; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

Review 7.  [Acute liver failure].

Authors:  K Rifai; M J Bahr
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

Review 8.  [Acute liver failure. Current aspects of diagnosis and therapy].

Authors:  M Bauer; M Paxian; A Kortgen
Journal:  Anaesthesist       Date:  2004-06       Impact factor: 1.041

9.  Assessment of resin perfusion in hepatic failure in vitro and in vivo.

Authors:  Ying-Jie Wang; Ze-Wen Wang; Bing-Wei Luo; Hong-Ling Liu; Hong-Wei Wen
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

Review 10.  The therapeutic potential of exosomes derived from different cell sources in liver diseases.

Authors:  Yun Pan; Wei-Feng Tan; Mu-Qing Yang; Ji-Yu Li; David A Geller
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-02-02       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.